Avgemsi

Avgemsi is part of the Nucleoside Metabolic Inhibitors class and treats Lung Cancer, Pancreatic Cancer, Breast Cancer and other conditions. Nucleoside metabolic inhibitors are used to treat colon cancer, breast cancer, leukemia, meningitis, actinic keratosis, skin cancer, pancreatic cancer, ovarian cancer, and lung cancer. They work by slowing down the growth of cancer cells which then kills the cell. Avgemsi is only available as a brand name drug.